Biomarkers Help Shape Diuretic use in Treating Acute Heart Failure Patients

By Meadowbrook Staff | August 3, 2019 |

According to a presentation at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC), Adrenomedullin activity predicts which acute heart failure patients (AHFP) are at the greatest risk of death without diuretic treatment post-discharge. “Therapy at discharge often remains unchanged for several weeks and even months in acute heart failure patients,”…

Read More